BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21829911)

  • 1. Creatine kinase levels in patients with bipolar disorder: depressive, manic, and euthymic phases.
    Feier G; Valvassori SS; Rezin GT; Búrigo M; Streck EL; Kapczinski F; Quevedo J
    Braz J Psychiatry; 2011 Jun; 33(2):171-5. PubMed ID: 21829911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functions and cognitive styles in young euthymic patients with bipolar I disorder.
    Fakhry H; El Ghonemy SH; Salem A
    J Affect Disord; 2013 Oct; 151(1):369-77. PubMed ID: 23830859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased uric acid levels in bipolar disorder: is it trait or state?
    Kesebir S; Süner O; Yaylaci ET; Bayrak A; Turan C
    J Biol Regul Homeost Agents; 2013; 27(4):981-8. PubMed ID: 24382179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder.
    De Berardis D; Conti CM; Campanella D; Carano A; Di Giuseppe B; Valchera A; Tancredi L; Serroni N; Pizzorno AM; Fulcheri M; Gambi F; Sepede G; Moschetta FS; Salerno RM; Ferro FM
    J Biol Regul Homeost Agents; 2008; 22(3):195-200. PubMed ID: 18842173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in manic bipolar patients: important, understated, significant aspects.
    Vrabie M; Marinescu V; Talaşman A; Tăutu O; Drima E; Micluţia I
    Ann Gen Psychiatry; 2015; 14():41. PubMed ID: 26609314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered serum levels of TNF-α, IL-6 and IL-18 in manic, depressive, mixed state of bipolar disorder patients.
    Luo Y; He H; Zhang M; Huang X; Fan N
    Psychiatry Res; 2016 Oct; 244():19-23. PubMed ID: 27455146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The purpose of early maladaptive schemas (EMS) in the relationship dysfunction among people with bipolar disorder in the euthymic phase.
    Dupouy M; Roux P; Munuera C; Weil F; Passerieux C; M'Bailara K
    Encephale; 2024 Jun; 50(3):265-274. PubMed ID: 37604720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the relationship between vitamin D and mania: correlations between serum vitamin D levels and disease activity.
    Altunsoy N; Yüksel RN; Cingi Yirun M; Kılıçarslan A; Aydemir Ç
    Nord J Psychiatry; 2018 Apr; 72(3):221-225. PubMed ID: 29308715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased uric acid levels in bipolar disorder subjects during different phases of illness.
    Albert U; De Cori D; Aguglia A; Barbaro F; Bogetto F; Maina G
    J Affect Disord; 2015 Mar; 173():170-5. PubMed ID: 25462413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood homocysteine concentration and mood disorders with mixed features among patients with alcohol use disorder.
    Oliva F; Coppola M; Mondola R; Ascheri D; Cuniberti F; Nibbio G; Picci RL
    BMC Psychiatry; 2017 May; 17(1):181. PubMed ID: 28494779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CK levels in unmedicated bipolar patients.
    Segal M; Avital A; Drobot M; Lukanin A; Derevenski A; Sandbank S; Weizman A
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):763-7. PubMed ID: 17628446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.
    Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV
    J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Kynurenine Metabolism During Depressive, Manic, and Euthymic Phases of Bipolar Affective Disorder.
    Maget A; Platzer M; Bengesser SA; Fellendorf FT; Birner A; Queissner R; Hamm C; Reininghaus B; Hecker A; Tomberger L; Pilz R; Dalkner N; Moll N; Schütze G; Schwarz M; Kapfhammer HP; Reininghaus EZ
    Curr Top Med Chem; 2020; 20(15):1344-1352. PubMed ID: 31376822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder.
    Bai YM; Su TP; Tsai SJ; Wen-Fei C; Li CT; Pei-Chi T; Mu-Hong C
    J Affect Disord; 2014 Sep; 166():187-92. PubMed ID: 25012430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder.
    De Berardis D; Conti CM; Campanella D; Carano A; Scali M; Valchera A; Serroni N; Pizzorno AM; D'Albenzio A; Fulcheri M; Gambi F; La Rovere R; Cotellessa C; Salerno RM; Ferro FM
    Int J Immunopathol Pharmacol; 2008; 21(2):319-24. PubMed ID: 18547475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum agouti-related protein (AgRP) levels in bipolar disorder: Could AgRP be a state marker for mania?
    Parlak N; Görgülü Y; Köse Çinar R; Sönmez MB; Parlak E
    Psychiatry Res; 2018 Feb; 260():36-40. PubMed ID: 29172096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smartphone data as an electronic biomarker of illness activity in bipolar disorder.
    Faurholt-Jepsen M; Vinberg M; Frost M; Christensen EM; Bardram JE; Kessing LV
    Bipolar Disord; 2015 Nov; 17(7):715-28. PubMed ID: 26395972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolvin D1 as a novel anti-inflammatory marker in manic, depressive and euthymic states of bipolar disorder.
    Kok Kendirlioglu B; Unalan Ozpercin P; Yuksel Oksuz O; Sozen S; Cihnioglu R; Kalelioglu T; Ilnem MC; Karamustafalioglu N
    Nord J Psychiatry; 2020 Feb; 74(2):83-88. PubMed ID: 31575320
    [No Abstract]   [Full Text] [Related]  

  • 20. Free Interval Duration: Clinical Evidence of the Primary Role of Excitement in Bipolar Disorder.
    Sani G; Simonetti A; Reginaldi D; Koukopoulos AE; Del Casale A; Manfredi G; Kotzalidis GD; Girardi P
    Curr Neuropharmacol; 2017 Apr; 15(3):394-401. PubMed ID: 28503111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.